KLK3 and Familial prostate cancer: In Europe, the randomized controlled trial on prostate cancer screening found that the benefit of PSA testing—one man saved from prostate cancer death per 781 men screened for 13 years—is outweighed by its harms by orders of magnitude—27 overtreated men per 781 screened men [18].